Patents by Inventor Robert Gristwood

Robert Gristwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidine
    Publication number: 20060167005
    Abstract: (4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)Thieno[2,3-D]Pyrimidine or a salt thereof has value in the treatment of fibromyalgia, obesity, weight gain and other conditions.
    Type: Application
    Filed: August 28, 2003
    Publication date: July 27, 2006
    Inventors: David Cavalla, Robert Gristwood
  • Topical formulation and use of buspirone
    Publication number: 20060088556
    Abstract: A liquid or semi-solid topical formulation of buspirone, when applied to human epidermis in vitro (following methods defined herein), results in a transepidermal flux rate of buspirone (individual or mean data) in one or more of the following ranges: 0.1 to 1.1 ?g/cm2/hour as assessed over 5 hours following application; 0.09 to 0.60 ?g/cm2/hour as assessed over 13 hours following application; 0.09 to 0.48 ?g/cm2/hour as assessed over 24 hours following application; 0.08 to 0.46 ?g/cm2/hour as assessed over 30 hours following application; and 0.08 to 0.39 ?g/cm2/hour as assessed over 48 hours following application. Buspirone is useful for the manufacture of a topical medicament for use in the treatment of pruritus or an immune-related skin disease.
    Type: Application
    Filed: March 22, 2004
    Publication date: April 27, 2006
    Inventors: David Cavalla, Robert Gristwood
  • Use of ppar activators for the treatment of pulmonary fibrosis
    Publication number: 20060013775
    Abstract: An activator of PPAR gamma is useful for the treatment of pulmonary fibrosis.
    Type: Application
    Filed: November 26, 2002
    Publication date: January 19, 2006
    Inventors: Robert Gristwood, David Cavalla, Hazel Bardsley
  • 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d)pyrimidine in the treatment of functional bowel disorder
    Publication number: 20050239792
    Abstract: Use of 4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)Thieno[2,3-D]Pyrimidine or a salt thereof for the manufacture of a medicament for the treatment of functional bowel disorder.
    Type: Application
    Filed: July 9, 2003
    Publication date: October 27, 2005
    Inventors: David Cavalla, Robert Gristwood
  • Use of 4-(2-flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d)-pyrimidine for treating of urinary incontinence
    Publication number: 20050222162
    Abstract: 4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)-Thieno(2,3-D)pyrimidine or a salt thereof is useful for the treatment of urinary incontinence.
    Type: Application
    Filed: January 29, 2003
    Publication date: October 6, 2005
    Inventors: David Cavalla, Robert Gristwood